In 2015, I successfully adopted an established editorial process, long overdue in our journal, Nuclear Medicine and Molecular Imaging. The first step was to invite Associate Editors who are in charge of handling manuscripts professionally and furthermore Associate Editors who specialize in radiochemistry and nuclear medicine physics. We the editors could successfully expand the disciplines in our nuclear medicine journal. The second was to recruit editorial board members who can help our journal's readers by writing about the perspectives and recent progress in the field of nuclear medicine as well as radiochemistry, nuclear medicine physics, and molecular imaging. Interestingly, Korean editorial board members have been fulfilling their duties of submitting review articles as well as chemistry-and physics-specialist editorial board members. I really appreciate the efforts and dedication of these members.
In 2016, I propose globalization of our journal as our shortterm vision; therefore, we needed to devise strategic plans to accomplish this goal. So far, few global colleagues have been interested in what we published and the topics being discussed in Nuclear Medicine and Molecular Imaging. The promotion of publication of review articles in 2015 was one of the proactive plans carried out successfully in radiochemistry and nuclear medicine physics and is still going on. In our new endeavor in 2016, in addition to inviting the submission of quality review articles, we are further going to promote the publication of original articles that meet the global standards for the quality of presentation and design. The fact that our journal is still not in the Science Citation Index is not a real problem if we can be confident that the presentation of our interests in our journal will shape the future of global nuclear medicine.
The Associate Editors and I have listed the potential reviewers from Asian countries including the established leaders from every country and the new Fellows of Asian Nuclear Medicine Boards (FANMB), which now number almost 100. By doing this, we are encouraging the interest of our colleagues in Asian developing countries for our journal. We now have another successful new journal, the Journal of Asia and Oceania Nuclear Medicine and Biology (JAONMB). We can cooperate with the leaders of this new journal for progress in Asian nuclear medicine. Positioning our journal in the global milieu of publishing will now provide a good direction for the future, considering that European colleagues have launched EJNMMI Research as well as EJNMMI Physics and EJNMMI Radiochemistry.
I think that the quality of the articles in our journal does not lie in the science or medicine as indicated by the journal's brand name, but depends more on the topics and quality of peer reviews of the articles. After 5 years and 1 more year after the globalization of our Korean Society's journal, having adopted the English language, we the Korean authors and also the future authors from Asian nations will make our journal very visionary and resourceful. The future of nuclear medicine really lies in the progress of Asian nuclear medicine, although the benchmarking sites in terms of quality and prospects exist in Europe or the USA as EJNMMI or JNM.
Please expect further progress of Nuclear Medicine and Molecular Imaging very soon and be confident that we are making a difference in the future of nuclear medicine globally. To achieve this goal, strengthening the detailed processes of guaranteeing the authenticity, integrity, novelty, and clinical contributions in the articles published in our journal is crucial. Thus, I really appreciate the efforts of my Associate Editors, Profs. Jae
